Browsing Category

24405 posts
Inspur Showcases Modular Construction Capability in Brisbane as Demand for Faster, Scalable Delivery Grows

Inspur Showcases Modular Construction Capability in Brisbane as Demand for Faster, Scalable Delivery Grows

Industry Leaders Examine Compliance Pathways, AI-Enabled Delivery Models, and Practical Strategies for…
Traveloka and Singapore Tourism Board launch regional campaign to inspire spontaneous weekend getaways to Singapore

Traveloka and Singapore Tourism Board launch regional campaign to inspire spontaneous weekend getaways to Singapore

SINGAPORE, Dec. 8, 2025 /PRNewswire/ — Traveloka, Southeast Asia’s leading travel platform, and…

Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting

NANJING, China, Dec. 8, 2025 /PRNewswire/ — From December 6 to 9,…

Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale

Fares as Low as TWD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/…

Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale

Fares as Low as HKD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/…
Agoda Unveils 2026 Travel Outlook Report: Key Trends for Industry Partners to Capitalize on the Year Ahead

Agoda Unveils 2026 Travel Outlook Report: Key Trends for Industry Partners to Capitalize on the Year Ahead

With interest in secondary destinations on the rise, expanding infrastructure and growing…

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ —…

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ — Innovent Biologics,…